SEC Comment Letter 0000000000-22-012900 to Apyx Medical Corp (APYX) (CIK 0000719135) (APYX)
Apyx Medical Corp (APYX) (CIK 0000719135)
Date: Nov. 30, 2022 · CIK: 0000719135 · Accession: 0000000000-22-012900
AI Filing Summary & Sentiment
File numbers found in text: 333-268532
Letter
United States securities and exchange commission logo November 29, 2022 Charles D. Goodwin II Chief Executive Officer Apyx Medical Corp. 5115 Ulmerton Road Clearwater, FL 33760 Re:Apyx Medical Corp. Registration Statement on Form S-3 Filed November 22, 2022 File No. 333-268532 Dear Charles D. Goodwin II: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Adam P. Silvers, Esq.
Show Raw Text
United States securities and exchange commission logo
November 29, 2022
Charles D. Goodwin II
Chief Executive Officer
Apyx Medical Corp.
5115 Ulmerton Road
Clearwater, FL 33760
Re:Apyx Medical Corp.
Registration Statement on Form S-3
Filed November 22, 2022
File No. 333-268532
Dear Charles D. Goodwin II:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Adam P. Silvers, Esq.